NCT07838181NARecruiting

Virtual Reality Aniseikonia and Metamorphopsia Testing

NYU Langone Health

Start Date

8/4/2026

Completion Date

6/30/2030

Summary

The purpose of this study is to assess whether the use of small, lightweight, portable virtual reality headset devices can provide a more accessible, reliable, contained, and convenient testing environment compared to previous platforms. Many tests only assess distortions in one plane or meridian and may have confounding effects from factors such as external stimuli or the use of colored filters to selectively display images to each eye. The investigators hypothesize that this device will help minimize, if not get rid of, a lot of these confounding factors that exist currently.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Over 18 years of age * Have no reported visual distortions with a negative Amsler test; or * Have visual distortions with a positive Amsler grid test and an ocular history of one of the following: epiretinal membrane (ERM), age-related Macular degeneration (AMD), central serous retinopathy (CSR), diabetic macular edema (DME), cystoid macular edema (CME) * Ophthalmology residents, staff, and physicians Exclusion Criteria: * Eye pathology limiting view to the posterior pole to obtain adequate quality fundus photograph or OCT imaging in either eye * Impaired visual acuity with best-corrected visual acuity equal to or worse than 20/70 * Motor deficits of the upper extremities

Interventions

DEVICE

Aegenta VR

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

MetamorphopsiaAniseikonia

Locations

NYU Langone Health

New York, New York 10016

United States